Fostering competition in the pharmaceutical distribution chain
A USC-Brookings Schaeffer Initiative for Innovation in Health Policy event
Past Event
Opening remarks and paper presentation
Opening remarks and paper presentation
Panel discussion: Fostering competition in the brand drug distribution chain
Paper presentation: Would price transparency for generic drugs lower costs for payers and patients?
Panel discussion: Fostering competition in the generic drug distribution chain
Although a great deal of attention concerning prescription drug prices centers on the prices charged by pharmaceutical manufacturers themselves, markups in the distribution chain—pharmacy benefit managers, wholesalers, and pharmacies—are often substantial. Despite the large role that these actors play, little is known about the discounts they negotiate or markups they charge and how those relate to what patients ultimately pay.
On Wednesday, June 14, the USC-Brookings Schaeffer Initiative for Innovation in Health Policy hosted a forum to explore the many segments of the drug distribution chain and examined proposals to reduce price markups through increased competition.
The event featured a presentation of two new papers: one estimating profitability in the distribution chains of both branded and generic drugs and another proposing a transparency scheme to foster competition in the distribution of generic pharmaceuticals. Stakeholder panels followed the presentations of these two papers, to discuss approaches to increase competition in brand and generic drug distribution.
Agenda
Opening Remarks
Dana Goldman
Leonard D. Schaeffer Director's Chair - Schaeffer Center for Health Policy & Economics
Distinguished Professor of Public Policy, Pharmacy, & Economics - Sol Price School of Public Policy and USC School of Pharmacy
Nonresident Senior Fellow - Economic Studies, Center for Health Policy
Paper presentation
The flow of funds in the pharmaceutical supply chain
Neeraj Sood
Professor, Vice Dean for Faculty Affairs, Vice Dean for Research - USC Price School of Public Policy, USC Schaeffer Center for Health Policy & Economics
Session Materials
Panel discussion
Fostering competition in the brand drug distribution chain
Paul B. Ginsburg
Nonresident Senior Fellow - Economic Studies, USC-Brookings Schaeffer Initiative for Health Policy
Senior Fellow - USC Schaeffer Center for Health Policy and Economics
Ed Adamcik
Chief Pharma Trade Relations Officer - Express Scripts
Jennifer Bryant
Senior Vice President, Policy and Research - Pharmaceutical Research and Manufacturers of America (PhRMA)
Matthew Eyles
Executive Vice President, Policy and Regulatory Affairs - AHIP
Paper presentation
Would Price Transparency for Generic Drugs Lower Costs for Payers and Patients?
Steven M. Lieberman
Nonresident Fellow - Economic Studies, USC-Brookings Schaeffer Initiative for Health Policy
Session Materials
Panel discussion
Fostering competition in the generic drug distribution chain
Darius Lakdawalla
Director of Research - USC Schaeffer Center for Health Policy & Economics
Quintiles Chair in Pharmaceutical Development and Regulatory Innovation - USC School of Pharmacy
Professor - USC Price School of Public Policy
Matthew Eyles
Executive Vice President, Policy and Regulatory Affairs - AHIP
B. Douglas Hoey
CEO - National Community Pharmacists Association
Tom Moriarty
Executive VP, Chief Policy & External Affairs Officer and General Counsel - CVS Health
Christine Simmon
Senior Vice President, Policy & Strategic Alliances - Association for Accessible Medicines
Executive Director - Biosimilars Council
More Information
To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.
